Companies seeking to benefit from campaign promises to cut regulations and taxes are ditching diversity and climate ...

Hims & Hers Health (NYSE:HIMS – Free Report) had its target price lifted by Piper Sandler from $21.00 to $24.00 in a report ...

Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

In recent trading, shares of Hims & Hers Health Inc (Symbol: HIMS) have crossed above the average analyst 12-month target price of $25.36, changing hands for $26.63/share. When a stock reaches the ...

Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been given a consensus recommendation of “Hold” by the ...

Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...

Hims & Hers (NYSE:HIMS) has donated $1 million to President-elect Donald Trump's inaugural committee. The telehealth brand ...

Piper Sandler raised the firm’s price target on Hims & Hers to $24 from $21 and keeps a Neutral rating on the shares. Heading into the new ...

Citi downgraded Hims & Hers to Sell from Neutral with a $25 price target Stay Ahead of the Market:Discover outperforming stocks and invest ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...